483
VitalantVitalant – FDA 483, Jun 19, 2019
Record Details
An FDA inspection of Vitalant, a blood bank and donor collection center in Lafayette, LA, identified a failure to maintain quality control records. Specifically, the firm lacked documentation of antigen typing quality control results for specific antigens on multiple dates. This indicates a deficiency in record-keeping practices for critical quality control procedures.
- Person
View Company Profile
ID · a1911bf5-5fda-4eb2-bf44-f4d815e5319c
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.